CHEST December 2021, Volume 160, Issue 6
Gerard A. Silvestri, MD, FCCP, and Adam H. Fox, MD, join CHEST Podcast Moderator Dominique Pepper, MD, to discuss the current knowledge and practice of pulmonologists regarding biomarker testing and targeted therapies in advanced non-small cell lung cancer.
DOI: https://doi.org/10.1016/j.chest.2020.08.1323
Mar 2
Adjunctive Corticosteroid Use and Clinical Outcomes in Non-HIV Pneumocystis jirovecii Pneumonia
Aaron M. Pulsipher, MD, joins CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss his research into the dose-response relationship between adjunctive corticosteroids and outcomes in adult patients with non-HIV Pneumocystis jirovecii pneumonia. DOI: 10.1016/j.chest.202 ... Show More
22m 46s
Mar 2
March 2026 CHEST Journal Editor Highlights
CHEST March 2026, Volume 169, Issue 3 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST March 2026 issue, including an investigation into a specialist dietary intervention in patients with fibrotic interstitial l ... Show More
18m 26s
Feb 16
CHEST Critical Care: The Impact of Mechanical Power Normalized to Predicted Body Weight on Outcomes in Pediatric ARDS
Authors Herng Lee Tan, MSc, and Judith Ju Ming Wong, MBBCh, BAO, and editorialist Vicent Modesto i Alapont, MD, PhD, join CHEST® Critical Care Podcast Moderator Dan Fein, MD, to discuss their research into the impact of mechanical power normalized to predicted body weight on outc ... Show More
34m 42s
Mar 2024
Episode 171: ASCO-GU Top Clinical Data With Pedro Barata
Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he de ... Show More
46m 7s
Jul 2023
Keeping Pace in Hematologic Malignancies: 2023 Contextualizing the Evidence: Newly Diagnosed AML in Difficult-to-Treat Subtypes
Host: Harry Paul Erba, MD, PhD Guest: Courtney DiNardo, MD Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Immuno-oncologic agents have changed the treatment landscape for non-small cell lung cancer. Listen as Drs. Harry Erba and Courtney DiNardo discuss ... Show More
23m 30s
May 2024
Ep. 172 HPV and Oropharyngeal Cancer: Evolving Insights and Implications with Dr. Mihir Patel
In this episode, Dr. Mihir Patel, Professor of Otolaryngology at Emory University and expert in Transoral Robotic Surgery (TORS), discusses HPV-positive head and neck cancer with host Dr. Ashley Agan. --- CHECK OUT OUR SPONSOR Medtronic ENT https://www.medtronic.com/en-us/healthc ... Show More
1h 7m
Oct 2022
Oct 14, 2022 This Week in Cardiology Podcast
<p>Chest pain evaluation in the ED, peer review, the NordICC trial, and a surgeon lost too early are the topics John Mandrola, MD, discusses in this week's podcast. <em>This podcast is intended for healthcare professionals only</em>. <u>To read a partial transcript or to comment, ... Show More
21m 21s
Jul 2021
Episode 39: R-CHOP versus DA-EPOCH-R for Double-Hit Lymphoma
Alan Skarbnik (@ASkarbnik), MD, director of the lymphoma and CLL program, Novant Health (Charlotte, NC), and Aaron Goodman (@AaronGoodman33), MD, hematologist, University of California San Diego, join the show for a long-awaited debate: treating double-hit lymphoma with R-CHOP vs ... Show More
1h 6m